|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: nuchal translucencyFrom: James S Smeltzer MD (gaperina@mindspring.com)Tue Aug 4 07:34:51 1998
Hi Tania, We are both right. The 30% you are talking about is 30% of the total incidence of Down's Syndrome that is detected by testing all with Maternal Age over 35. The amniotic fluid cell culture, Chromosome count and Karyotype test itself will detect essentially all (with a small allowances for mosaic translocations and lab error) babies with Down's syndrome whose cells are tested. The newer, much faster and much cheaper fluorescent in situ hybridzation test will detect about 99Plus percent. This is not approved by the American Society of Human Genetics because it will put many of them out of business. I hope this helps. Jim Smeltzer (gaperina@mindspring.com)
At 07:17 PM 8/3/1998 -0500, you wrote:
>In a message dated 03/08/98 12:11:47 GMT, gaperina@mindspring.com writes:
|
|
Return to
|
Mail a New Message to the Forum: ultrasound@obgyn.net Forum Administrator: terry.dubose@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:39:05 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.